n-acetylcysteine-lysinate and Acute-Lung-Injury

n-acetylcysteine-lysinate has been researched along with Acute-Lung-Injury* in 1 studies

Other Studies

1 other study(ies) available for n-acetylcysteine-lysinate and Acute-Lung-Injury

ArticleYear
Softness enhanced macrophage-mediated therapy of inhaled apoptotic-cell-inspired nanosystems for acute lung injury.
    Journal of nanobiotechnology, 2023, May-30, Volume: 21, Issue:1

    Engineered nanosystems offer a promising strategy for macrophage-targeted therapies for various diseases, and their physicochemical parameters including surface-active ligands, size and shape are widely investigated for improving their therapeutic efficacy. However, little is known about the synergistic effect of elasticity and surface-active ligands. Here, two kinds of anti-inflammatory N-acetylcysteine (NAC)-loaded macrophage-targeting apoptotic-cell-inspired phosphatidylserine (PS)-containing nano-liposomes (PSLipos) were constructed, which had similar size and morphology but different Young's modulus (E) (H, ~ 100 kPa > E

    Topics: Acetylcysteine; Acute Lung Injury; Animals; Lung; Macrophages; Mice

2023